Manuel J Glynias

Mr. Glynias is a serial entrepreneur with over 25 years of experience in bioinformatics. Immediately prior to GenomOncology, Manuel was a partner at Rosetta, a leading interactive marketing agency, where he helped develop big data solutions for ecommerce clients. In the late 90’s, Manuel was the founder and CEO of NetGenics, a venture-backed provider of discovery informatics to the biopharmaceutical industry and academic research centers. He also developed a number of other commercial software platforms including MacGene, Gene Works, and Primer Express. Manuel has an AB in Biochemistry and Molecular Biology from Harvard College.

Victor Peroni

Victor Peroni

Chief Financial Officer, is an accomplished senior executive with 24+ years of business experience ranging from Finance and Operations to Sales and Marketing.  Prior to joining GO, Vic served as President of Hebron USA, Corp and COO of Ganeden Biotech.  He has worked at various startups, as well as more established companies that have included private, international, angel and venture investor groups.  Vic has also helped to grow and position various companies for merger or acquisition.  He has worked with some of the largest retailers in the world including Walmart, Walgreens and CVS and holds a BA in Accounting from Baldwin-Wallace University.

David Lasecki

David Lasecki

Chief Strategy Officer, has more than 16 years of specialty pharmaceutical and molecular diagnostic experience. David most recently served as president of CompanionDx Labs where he developed sales, marketing, and payor strategies for its pharmacogenomics and oncology test offerings. Prior to that, David held a variety of sales and new business development roles with AmerisourceBergen’s specialty group, International Oncology Network, where he worked closely with leading community oncology practices and branded and generic pharmaceutical manufacturers. David holds a BA from the University of Mount Union.

Teresa Fletcher, CHP

Vice President of Business Development, is a seasoned business development professional with a deep understanding of oncology and the healthcare ecosystem. Teresa has over 17 years experience with enterprise solution sales within the healthcare provider space along with a comprehensive knowledge and expertise pertaining to maximizing the effectiveness of healthcare data, managing outcomes, and informatics strategy. Prior to joining GenomOncology, Teresa has held positions in various healthcare startups within sales and customer management in the healthcare IT, healthcare informatics, and medical device industries. Teresa received her Bachelor of Arts from Lafayette College and is a Certified HIPAA Professional who serves in an advisory role to many of her provider clients with her experience in data protection and data sharing.

Ian Maurer

Vice President of Product Development, leads the full lifecycle of application design, architecture, development, and quality assurance. Ian has 17 years of software development and leadership experience working for Lockheed Martin, Ernst & Young, Brulant and Rosetta. He has his Bachelors and Masters degrees in Computer Engineering from Syracuse University.